載入...
miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway
Diabetic cardiomyopathy (DCM) is a common heart disease. The Phase II enzyme inducer (CPDT) is a complex enzyme that promotes the expression of antioxidant enzymes through activating nuclear factor erythroid 2-related factor 2 (Nrf2); these compounds have been shown to protect against oxidative stre...
Na minha lista:
| 發表在: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5748299/ https://ncbi.nlm.nih.gov/pubmed/29404371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9167450 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|